Camila Schlang Cabral da Silveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camila Schlang Cabral da Silveira has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Luna Azulay‐Abulafia
Pedro Ernesto University Hospital – State University of Rio de Janeiro (HUPE – UERJ) Rio de Janeiro Brazil
4 shared publications - Carlos Baptista Barcaui
Instituto de Dermatologia Prof. Rubem David Azulay, Santa Casa da Misericórdia do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
2 shared publications - Daniel Lago Obadia
Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
2 shared publications - Luiz Felipe Oliveira Santos
Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
2 shared publications - Marcella Leal Novello D’eLia
Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
2 shared publications - Renata Miguel Quirino
Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 May 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (3) , 467-471
Siringofibroadenoma écrino: dois relatos de casos exuberantes
- 1 May 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (3) , 467-471
Open AccessSiringofibroadenoma écrino: dois relatos de casos exuberantes
- Open Access
- 24 February 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (3) , 467-471
Eccrine syringofibroadenoma: report of two exuberant cases
- 24 February 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (3) , 467-471
Open AccessEccrine syringofibroadenoma: report of two exuberant cases
- Open Access
- 1 January 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (1) , 127-129
Linfangioma circunscrito avaliado por microscopia confocal
- 1 January 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (1) , 127-129
Open AccessLinfangioma circunscrito avaliado por microscopia confocal
- 28 November 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (2) , 224-231
Analysis of the use of isotretinoin as an adjuvant in rhinoplasty
Background: Isotretinoin has been used in the treatment of acne for decades through the reduction of sebaceous secretion. There are reports in the literature that isotretinoin may be associated with decreased skin thickness, especially in patients with thick nasal skin for whom rhinoplasty can be more challenging. The objective of this study was to quantify, through ultrasonography, the effect of the use of oral isotretinoin in patients undergoing rhinoplasty, pre‐ and postoperatively.Methods: Twenty‐four patients participated in this randomized, single‐blind controlled pilot clinical trial. The intervention group used oral isotretinoin (20 mg/day) for 2 months before rhinoplasty and for 4 months after. Both groups underwent rhinoplasty in the same plastic surgery department and were submitted to high‐frequency (22 MHz) ultrasound evaluation of the epidermis and dermis on the nasal dorsum, nasal tip, and left nose wing at the beginning of the study and 6 months after rhinoplasty, with the aim of assessing changes in skin thickness.Results: Six months after rhinoplasty, a statistically significant reduction was observed in the thickness of the epidermis and dermis of the nasal dorsum and left nose wing, as well as of the epidermis of the nasal tip, but only in the intervention group. The results of the satisfaction questionnaire were better after rhinoplasty in both groups, with no statistical difference between them regarding the specific questions; however, the intervention group had significantly higher satisfaction scores than the control group.Conclusions: Isotretinoin was effective in reducing the thickness of the skin covering the nose of the evaluated sites.
- 28 November 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (2) , 224-231
Analysis of the use of isotretinoin as an adjuvant in rhinoplasty
Background: Isotretinoin has been used in the treatment of acne for decades through the reduction of sebaceous secretion. There are reports in the literature that isotretinoin may be associated with decreased skin thickness, especially in patients with thick nasal skin for whom rhinoplasty can be more challenging. The objective of this study was to quantify, through ultrasonography, the effect of the use of oral isotretinoin in patients undergoing rhinoplasty, pre‐ and postoperatively.Methods: Twenty‐four patients participated in this randomized, single‐blind controlled pilot clinical trial. The intervention group used oral isotretinoin (20 mg/day) for 2 months before rhinoplasty and for 4 months after. Both groups underwent rhinoplasty in the same plastic surgery department and were submitted to high‐frequency (22 MHz) ultrasound evaluation of the epidermis and dermis on the nasal dorsum, nasal tip, and left nose wing at the beginning of the study and 6 months after rhinoplasty, with the aim of assessing changes in skin thickness.Results: Six months after rhinoplasty, a statistically significant reduction was observed in the thickness of the epidermis and dermis of the nasal dorsum and left nose wing, as well as of the epidermis of the nasal tip, but only in the intervention group. The results of the satisfaction questionnaire were better after rhinoplasty in both groups, with no statistical difference between them regarding the specific questions; however, the intervention group had significantly higher satisfaction scores than the control group.Conclusions: Isotretinoin was effective in reducing the thickness of the skin covering the nose of the evaluated sites.
- Open Access
- 22 September 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (1) , 127-129
Confocal evaluation of lymphangioma circumscriptum
- 22 September 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (1) , 127-129
Open AccessConfocal evaluation of lymphangioma circumscriptum
- 18 April 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (7) , 924-932
Comedonic lupus, a rare variant of chronic cutaneous lupus erythematosus (CCLE): case series and literature review
Background: Cutaneous lupus erythematosus (CLE) is an autoimmune disease with several clinical presentations. The chronic form predominantly presents as discoid rashes but may present with less common morphological findings that can sometimes make diagnosis difficult. Comedonic lupus is a rare and underdiagnosed variant, with unknown etiology and still poorly defined treatment.Methods: The report illustrates a series of five cases of patients diagnosed with comedonic lupus, and it reviews 18 cases previously published in the literature.Results: The clinical presentation is of comedonal lesions, mostly located on the face, making a differential diagnosis with other benign conditions such as acne vulgaris, Favre‐Racouchot syndrome, and syringoma, emphasizing the importance of clinical practice and histopathology for diagnostic confirmation.Conclusions: There is scarcity in the literature regarding the condition and therapeutic possibilities for these cases of comedonic lupus.
- 18 April 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (7) , 924-932
Comedonic lupus, a rare variant of chronic cutaneous lupus erythematosus (CCLE): case series and literature review
Background: Cutaneous lupus erythematosus (CLE) is an autoimmune disease with several clinical presentations. The chronic form predominantly presents as discoid rashes but may present with less common morphological findings that can sometimes make diagnosis difficult. Comedonic lupus is a rare and underdiagnosed variant, with unknown etiology and still poorly defined treatment.Methods: The report illustrates a series of five cases of patients diagnosed with comedonic lupus, and it reviews 18 cases previously published in the literature.Results: The clinical presentation is of comedonal lesions, mostly located on the face, making a differential diagnosis with other benign conditions such as acne vulgaris, Favre‐Racouchot syndrome, and syringoma, emphasizing the importance of clinical practice and histopathology for diagnostic confirmation.Conclusions: There is scarcity in the literature regarding the condition and therapeutic possibilities for these cases of comedonic lupus.